| http://www.w3.org/ns/prov#value | - Payers such as Medicaid, Medicare, private insurers, and AIDS Drug Assistance Programs should support adherence interventions with this degree of efficacy so as to maximize the benefit of combination antiretroviral therapy in patients with a history of adherence problems.
|
